Company Data

Heron Therapeutics Inc.

Ticker
HRTX
Current Price
$2.95 -0.67%
Market Cap
$443.5M
Price Target
Refer to Report
Volume
1.3M
52wk Range
$0.5 - $3.22
Advanced Market Data

Overview

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company’s product portfolio consists of SUSTOL and CINVANTI. Its pipeline product is HTX-011.

Inbox Intel from Channelchek.

Informed investors make more money. And itโ€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
ยฉ 2018-2024 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.